439 related articles for article (PubMed ID: 12446788)
21. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).
Leu SJ; Liu Y; Chen N; Chen CC; Lam SC; Lau LF
J Biol Chem; 2003 Sep; 278(36):33801-8. PubMed ID: 12826661
[TBL] [Abstract][Full Text] [Related]
22. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.
Chen CC; Chen N; Lau LF
J Biol Chem; 2001 Mar; 276(13):10443-52. PubMed ID: 11120741
[TBL] [Abstract][Full Text] [Related]
23. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate.
Fataccioli V; Abergel V; Wingertsmann L; Neuville P; Spitz E; Adnot S; Calenda V; Teiger E
Hum Gene Ther; 2002 Aug; 13(12):1461-70. PubMed ID: 12215267
[TBL] [Abstract][Full Text] [Related]
25. Role of CCN, a vertebrate specific gene family, in development.
Katsube K; Sakamoto K; Tamamura Y; Yamaguchi A
Dev Growth Differ; 2009 Jan; 51(1):55-67. PubMed ID: 19128405
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions.
Schober JM; Lau LF; Ugarova TP; Lam SC
J Biol Chem; 2003 Jul; 278(28):25808-15. PubMed ID: 12736251
[TBL] [Abstract][Full Text] [Related]
27. Functional properties and intracellular signaling of CCN1/Cyr61.
Chen Y; Du XY
J Cell Biochem; 2007 Apr; 100(6):1337-45. PubMed ID: 17171641
[TBL] [Abstract][Full Text] [Related]
28. The circulating proangiogenic factors CYR61 (CCN1) and NOV (CCN3) are significantly decreased in placentae and sera of preeclamptic patients.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Winterhager E
Reprod Sci; 2007 Dec; 14(8 Suppl):46-52. PubMed ID: 18089610
[TBL] [Abstract][Full Text] [Related]
29. Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins.
Chaqour B; Goppelt-Struebe M
FEBS J; 2006 Aug; 273(16):3639-49. PubMed ID: 16856934
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.
Athanasopoulos AN; Schneider D; Keiper T; Alt V; Pendurthi UR; Liegibel UM; Sommer U; Nawroth PP; Kasperk C; Chavakis T
J Biol Chem; 2007 Sep; 282(37):26746-26753. PubMed ID: 17626014
[TBL] [Abstract][Full Text] [Related]
31. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
Babic AM; Kireeva ML; Kolesnikova TV; Lau LF
Proc Natl Acad Sci U S A; 1998 May; 95(11):6355-60. PubMed ID: 9600969
[TBL] [Abstract][Full Text] [Related]
32. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.
Grzeszkiewicz TM; Kirschling DJ; Chen N; Lau LF
J Biol Chem; 2001 Jun; 276(24):21943-50. PubMed ID: 11287419
[TBL] [Abstract][Full Text] [Related]
33. The matrix protein CCN1 (CYR61) promotes proliferation, migration and tube formation of endothelial progenitor cells.
Yu Y; Gao Y; Wang H; Huang L; Qin J; Guo R; Song M; Yu S; Chen J; Cui B; Gao P
Exp Cell Res; 2008 Oct; 314(17):3198-208. PubMed ID: 18755182
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis.
Sawai K; Mori K; Mukoyama M; Sugawara A; Suganami T; Koshikawa M; Yahata K; Makino H; Nagae T; Fujinaga Y; Yokoi H; Yoshioka T; Yoshimoto A; Tanaka I; Nakao K
J Am Soc Nephrol; 2003 May; 14(5):1154-63. PubMed ID: 12707386
[TBL] [Abstract][Full Text] [Related]
35. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.
Walker TM; Van Ginkel PR; Gee RL; Ahmadi H; Subramanian L; Ksander BR; Meisner LF; Albert DM; Polans AS
Arch Ophthalmol; 2002 Dec; 120(12):1719-25. PubMed ID: 12470148
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.
Han JS; Macarak E; Rosenbloom J; Chung KC; Chaqour B
Eur J Biochem; 2003 Aug; 270(16):3408-21. PubMed ID: 12899698
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
[TBL] [Abstract][Full Text] [Related]
39. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium.
Gashaw I; Stiller S; Böing C; Kimmig R; Winterhager E
Endocrinology; 2008 May; 149(5):2261-9. PubMed ID: 18202125
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
